Abilify and Affect lability - a phase IV clinical study of FDA data
Summary:
Affect lability is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Cymbalta, and have Stress and anxiety.
The phase IV clinical study analyzes which people have Affect lability when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.
What is Affect lability?
Affect lability (emotional incontinence) is found to be associated with 695 drugs and 827 conditions by eHealthMe. Check the latest studies of Affect lability.
97,308 people reported to have side effects when taking Abilify.
Among them, 131 people (0.13%) have Affect lability.
Among these 131 people:
How long have people been on Abilify when they have Affect lability? *
What is the gender of people who have Affect lability when taking Abilify? *
What is the age of people who have Affect lability when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Affect lability? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Affect lability?
- Check whether Affect lability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,450 reports)
Affect lability treatments and more:
- Affect lability (13,491 reports)
How severe was Affect lability and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Affect lability:
- Affect lability (695 drugs)
Browse all the conditions that are associated with Affect lability:
- Affect lability (827 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Prednisolone and Methylprednisolone Acetate - 5 seconds ago
- Drug interactions of Cosentyx and Elavil - 6 seconds ago
- Remicade and Death for Women aged 50-59 - 7 seconds ago
- Remicade and Death Sudden for Women aged 50-59 - 8 seconds ago
- Amlodipine and Side Pain for Men aged 50-59 - 8 seconds ago
- Remicade and Sudden Death for Women aged 50-59 - 9 seconds ago
- Amlodipine and Pain - Side for Men aged 50-59 - 9 seconds ago
- Could Potassium Chloride cause Blood Glucose Decreased? - 9 seconds ago
- Amlodipine and Flank Pain for Men aged 50-59 - 9 seconds ago
- Drug interactions of Vraylar and Zoloft - 12 seconds ago